Location History:
- Tokyo JP (2006 - 2009)
- Tokyo, JP (2010 - 2011)
Company Filing History:
4 out of 846 
4 out of 832,891 Years Active: 2006-2011
Title: The Innovations of Yoji Ikawa
Introduction
Yoji Ikawa is a notable inventor based in Tokyo, Japan, recognized for his contributions to genetic research. With a total of four patents to his name, Ikawa has focused on advancing the understanding of human genes and their role in cell regulation, particularly concerning the p53 gene.
Latest Patents
Among his latest innovations, Ikawa has developed patents related to human p51 genes and their gene products. These patents introduce novel human genes that belong to the family of genes associated with the p53 gene, known for its critical role in regulating cell proliferation. Specifically, his work encompasses a human p51 gene characterized by a base sequence encoding an amino acid sequence represented by SEQ ID NO:1. Additionally, he has described a human p51 gene with a base sequence ranging from 145 to 1488 bases in sequence SEQ ID NO:2. The patents also encompass vectors that contain these genes, host cells transformed with these vectors, and a comprehensive process for producing a p51 protein, which is vital for various biological applications.
Career Highlights
Yoji Ikawa has had an impactful career, including his tenure at Otsuka Pharmaceutical Company, Limited. His work at this prominent institution has significantly contributed to the foundation of his innovative patents and furthered his research in the field of genetics.
Collaborations
During his career, Ikawa has worked alongside notable colleagues such as Shuntaro Ikawa and Masuo Obinata. These collaborations have likely enriched his research endeavors and led to further advancements in genetic innovations.
Conclusion
Yoji Ikawa's work exemplifies the intersection of science and innovation, particularly in genetics. His patents on human p51 genes represent significant breakthroughs that have the potential to enhance our understanding of cell proliferation and regulation, contributing valuable insights to the field of biotechnology.